OU will expand the nationally recognized Stephenson Cancer Center research ecosystem with focus on reducing incidence, improving early detection, and delivering more effective, personalized therapies for cancers that disproportionately affect Oklahomans.
This effort will strengthen OU’s ability to translate discovery into clinical benefit while addressing disparities in cancer outcomes across rural, Tribal, and underserved communities.
Stephenson Cancer Center serves as a major source of biomedical discovery into the nature of cancer and for the development of new and more effective treatments. It's 130 member investigators are currently working on more than 400 cancer research projects, supported by $65 million of annual research funding from the National Institutes of Health, American Cancer Society and others. This team has published more than 1450 scientific articles over the past five years, advancing science and influencing how patients are treated in Oklahoma and around the world.
The University of Oklahoma College of Medicine has named Kelly Stratton, M.D., FACS as associate dean for veterans affairs, pending approval by the OU Board of Regents.
The Oklahoma Tobacco Settlement Endowment Trust (TSET) has awarded the University of Oklahoma a $25 million grant to help construct a new OU Health Stephenson Cancer Center facility in Tulsa, a project that will house the newly named TSET Clinical Research Center and significantly expand access to clinical trials and cancer care in the region.
University of Oklahoma researcher Elizabeth Wellberg, Ph.D., is the senior author of a review article in The Journal of Clinical Investigation that gathers current research evidence about the effects of GLP-1 drugs, like Ozempic and Zepbound, on cancer risk.
OU Health Stephenson Cancer Center today celebrated the groundbreaking of its new 176,000-square-foot facility on the University of Oklahoma’s Schusterman Center campus, marking a transformative step forward in expanding access to National Cancer Institute-designated cancer care for thousands of residents in northeast Oklahoma.
The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part by the University of Oklahoma Health Stephenson Cancer Center.
Citing a background of innovative cancer research, the Indian National Science Academy (INSA) has elected OU’s Priyabrata Mukherjee, Ph.D., as a foreign fellow. His fellowship will begin Jan. 1, 2026.
With a new grant from the National Institutes of Health, the University of Oklahoma Health Stephenson Cancer Center is growing its mission of building the next generation of health professionals.
On Tuesday, OU Health Stephenson Cancer Center celebrated the expansion of its Oklahoma Phase 1 Clinical Trials Center, which will soon double the number of patients receiving early-stage cancer drugs. In addition, nearly 20,000 square feet of laboratory space has been added on the OU Health Campus to support the growth of cancer research.
A smartphone app that delivers real-time, tailored messages may hold the key to helping low-income smokers quit, according to University of Oklahoma clinical trial results published today in JAMA Network Open.
The University of Oklahoma College of Medicine is pleased to announce the appointment of Christina E. Henson, M.D., as Executive Vice Chair of the Department of Radiation Oncology.
